Earth Science Tech Inc. (OTC: ETST) is executing a strategy centered on vertical integration and synergistic operations across its subsidiaries, positioning the company for cash-flow-driven growth without relying on equity dilution. The diversified holding company, which operates through RxCompoundStore (RxCS), Mister Meds, and Peaks Curative LLC, has created a healthcare platform that encompasses compounding pharmacy, telemedicine, and direct-to-consumer fulfillment.
RxCS, a Miami-based licensed compounding pharmacy, produces sterile and non-sterile custom medications. Mister Meds, located in Abilene, Texas, specializes in sterile compounding and handling hazardous drugs. Together, these pharmacies supply wholesale medications to independent clinics while also fulfilling prescriptions directly to patients through Peaks Curative LLC. This dual-market approach reduces dependence on any single segment, according to the company.
In fiscal year 2026, Earth Science Tech reported a reduction in total liabilities and an increase in total assets, resulting in a net increase in shareholder equity. The company emphasized that its growth strategy is dilution-free, meaning it does not rely on issuing new shares to fund operations. This financial discipline is supported by the recurring revenue streams from its compounding pharmacies and the integration of telemedicine services.
Peaks Curative LLC serves as the fulfillment arm, connecting patients with customized medications produced by RxCS and Mister Meds. The vertical integration allows Earth Science Tech to control the supply chain from consultation to delivery, potentially improving margins and patient outcomes. The company’s newsroom provides updates on its progress at https://ibn.fm/ETST.
The announcement comes as the healthcare industry increasingly values integrated care models that reduce costs and improve access. By combining compounding pharmacy operations with telemedicine, Earth Science Tech aims to serve both wholesale clients and individual consumers, creating a resilient business model. The company’s focus on reducing liabilities while growing assets underscores its commitment to financial health.
Investors and industry observers are watching how Earth Science Tech’s platform evolves, particularly as regulatory landscapes around compounding pharmacies and telemedicine continue to shift. The company’s ability to maintain dilution-free growth while expanding its market presence will be a key factor in its long-term success.
